Skip to main content
MDT
NYSE Industrial Applications And Services

Medtronic Sets Final Exchange Ratio of 4.5939x for MiniMed Split-Off

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$85.65
Mkt Cap
$109.379B
52W Low
$73.31
52W High
$106.33
52W Position info
17% above low
Off High info
19% below high
Rel. Volume info
4.8× avg
Market data snapshot near publication time

MDT sits 17% above its 52-week low of $73.31 on elevated volume (4.8× avg).

Summary

Medtronic confirmed the final exchange ratio of 4.5939x for its MiniMed Group split-off, with the upper limit in effect. The exchange offer expires October 9, 2026, with shareholders receiving approximately $107.53 of MiniMed stock per $100 of Medtronic shares tendered.


Key Events · M&A and Partnerships · MDT

  • Final Exchange Ratio Confirmed

    The final exchange ratio has been confirmed at 4.5939 shares of MiniMed Common Stock per Medtronic Ordinary Share, with the upper limit in effect as of October 7, 2026.

  • Exchange Offer Expiration

    The exchange offer expires at 12:00 midnight New York City time on October 9, 2026, unless extended or terminated.

  • Premium to Tendered Shares

    Shareholders receive approximately $107.53 of MiniMed Common Stock for each $100 of Medtronic Ordinary Shares accepted, subject to the upper limit of 4.5939 shares.

  • VWAP Pricing Data

    The final ratio was determined using three-day VWAP averaging: Medtronic at $85.9179 and MiniMed at $19.2135 on October 7, 2026.


Analysis · MDT · Industrial Applications And Services

The final exchange ratio for the MiniMed Group split-off has been confirmed at 4.5939 shares of MiniMed Common Stock per Medtronic Ordinary Share, with the upper limit now in effect. Shareholders who tender their Medtronic shares will receive approximately $107.53 of MiniMed stock for each $100 of Medtronic shares accepted, and the offer is set to expire on October 9, 2026. The ratio was determined using the three-day VWAP averaging period ending October 7, 2026, during which Medtronic traded at $85.9179 and MiniMed at $19.2135. This confirms the mechanics of a transaction that will split off at least 80.1% of MiniMed Group, creating a new publicly traded diabetes technology company while Medtronic shareholders receive a premium for their tendered shares.

How filings like this one have moved

In the 30 days to Oct 7, 2026, 29% of the 1648 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.62%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MDT was trading at $85.65 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $109.4B. The 52-week trading range was $73.31 to $106.33. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDT - Latest Insights

MDT
Sep 14, 2026, 8:00 AM EDT
Filing Type: SC TO-I
Importance Score:
9
MDT
Sep 14, 2026, 7:40 AM EDT
Filing Type: 425
Importance Score:
9
MDT
Sep 03, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
7
MDT
Sep 02, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
MDT
Sep 01, 2026, 6:55 AM EDT
Source: Reuters
Importance Score:
8